A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC
Status:
Terminated
Trial end date:
2019-01-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the combination of MM-121 plus docetaxel is
more effective than docetaxel alone in regards to PFS in patients with heregulin-positive
NSCLC.